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T Cell Receptor Recognition Motifs Govern
Immune Escape Patterns in Acute SIV Infection
that characterizes infection with AIDS viruses is a sub-
stantial barrier to the development of successful vac-
cines and therapeutic interventions based on manipula-
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perspective, it is essential to gain an integrated pictureNorman L. Letvin,4 Genoveffa Franchini,3
Steven M. Wolinsky,5 Richard A. Koup,2 of the controlling influences that underlie the complex
relationship between retroviruses and CD8 T cell im-and Daniel C. Douek1,*
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It is clear that the survival advantage possessed by2 Immunology Laboratory
Vaccine Research Center viral variants with immune escape properties is most
apparent at the extremes of infection in the presenceNIAID/NIH
3 Center for Cancer Research of immunodominant CD8 T cell responses; under these
conditions, a focused selection force of considerableNCI/NIH
Bethesda, Maryland 20892 magnitude operates on a large virus population under-
going rapid replication (Allen et al., 2000; Borrow et al.,4 Division of Viral Pathogenesis
Beth Israel Deaconess Medical Center 1997; Goulder et al., 1997; Kelleher et al., 2001; Price et
al., 1997). However, even in these circumstances, theHarvard Medical School
Boston, Massachusetts 02215 emergence of escape mutations within targeted T cell
epitopes is not an inevitable consequence; such incon-5 Department of Medicine
Northwestern University Feinberg School sistency suggests that additional factors influence the
outcome of host/pathogen interactions in this setting.of Medicine
Chicago, Illinois 60611 Recent studies have identified several virologic and im-
munologic factors that can influence the process of mu-
tational escape; these include viral fitness constraints
and qualitative aspects of the host CD8 T cell responseSummary
such as specificity and functional avidity (Friedrich et
al., 2004a; Leslie et al., 2004; O’Connor et al., 2002;Escape from adaptive T cell immunity through trans-
mutation of viral antigenic structure is a cardinal fea- Peyerl et al., 2003; Wagner et al., 1999; Yang et al.,
2003a, 2003b). However, the impact of T cell receptorture in the pathogenesis of SIV/HIV infection and a
major obstacle to antiretroviral vaccine development. (TCR)-antigen interactions at the molecular level re-
mains uncertain.However, the molecular determinants of this phenom-
enon at the T cell receptor (TCR)-antigen interface are Here, we undertook a large-scale analysis of virus-
specific TCR sequences in the simian immunodeficiencyunknown. Here, we show that mutational escape is
intimately linked to the structural configuration of con- virus (SIV)-rhesus macaque model to investigate the hy-
pothesis that the nature of antigen engagement playsstituent TCR clonotypes within virus-specific CD8
T cell populations. Analysis of 3416 SIV-specific TCR a formative role in the dynamic process of viral escape
from T cell recognition. The potential for multiple T cellsequences revealed that polyclonal T cell populations
characterized by highly conserved TCRB CDR3motifs clonotypes to target a single peptide-major histocom-
patibility complex (pMHC) antigen is a function of thewere rendered ineffectual by single residue mutations
in thecognate viral epitope.Conversely, diverseclono- intrinsic crossreactivity that characterizes TCR recogni-
tion (Mason, 1998; Nikolich-Zugich et al., 2004). It istypic repertoires without discernible motifs were not
associatedwith viral escape.Thus, fundamental differ- therefore conceivable that diversity patterns within the
highly variable complementarity determining regionsences in the mode of antigen engagement direct the
pattern of adaptive viral evolution. These findings have (CDRs) that define TCR specificity could shape viral
evolution and thereby influence the outcome of in-profound implications for the development of vaccines
that elicit T cell immunity to combat pathogens with fection.
unstable genomes.
Results and Discussion
Introduction
Clonotypic Characterization of Immunodominant
Antiviral CD8 T cell activity is crucial for immune-medi- SIV-Specific CD8 T Cell Responses
ated control of SIV/HIV replication, but the efficacy of The clonal structure of immunodominant virus-specific
this response is limited by continuous shifts in antigen CD8 T cell responses was examined in 12 Mamu-A*01
topography that exemplify adaptive viral evolution to the rhesus macaques with primary SIVmac251 infection
individual host environment (Johnson and Desrosiers, (Figure 1). In this model, acute phase CD8 T cell re-
2002; Letvin and Walker, 2003; McMichael, 1998). In- sponses directed against the TL8 (TTPESANL; Tat, resi-
deed, this process of immune evasion through mutation dues 28–35) and CM9 (CTPYDINQM; Gag, residues 181–
189) epitopes bound to Mamu-A*01 are typically
codominant (Mothe et al., 2002); inherent controls are*Correspondence: ddouek@nih.gov
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amplicons were cloned and sequenced. At least 50 such
clones were analyzed for each isolated epitope-specific
T cell population at both time points in every macaque.
The amino acid sequences spanning the expressed
CDR3s formed at the TCRB VDJ junctional region are
shown for all 3416 TCR sequences in Supplemental Fig-
ures S1 and S2; representative data from three ma-
caques are shown in Figures 2 and 3.
Analysis of Clonal Diversity
Analysis of TCRB gene usage demonstrated that both
SIV-specific CD8 T cell populations were polyclonal
early after infection (range: 20–44 clones, median: 28
clones, for TL8-specific responses; range: 12–40 clones,
median: 26 clones, for CM9-specific responses) (Figure
4). At 12 weeks postinfection, the TL8-specific response
remained polyclonal, with two notable exceptions
(range: 1–42, median: 30.5). The CM9-specific response,
in contrast, exhibited reduced clonality at the later time
point (range: 6–25, median: 20). This contraction was
statistically significant (p  0.0186; Figure 4F) and, to-
gether with the observed chronological shifts in clono-
type prevalence within each macaque (Figure 3 and Sup-
plemental Figure S2), is consistent with the notion of
specific T cell population avidity maturation in the pres-
ence of a persistent antigenic stimulus (Kedl et al., 2003).
No significant correlations were observed between
plasma virus load (pVL), response magnitude, and clon-
ality for either the TL8- or CM9-specific CD8 T cell
populations at either time point (data not shown).
Patterns of TCRBV Gene Usage
Remarkably conserved patterns of TCRBV gene usage
were apparent (Figure 5). Preferential expression of
TCRBV13 was observed in the majority of CM9-specific
CD8 T cell populations (8/12 macaques at 5 weeks
after infection), a finding that is consistent with those
from previous studies (Chen et al., 2001). In contrast,
despite the common MHC class I restriction, TL8-spe-
cific CD8 T cells expressed predominantly TCRBV14
Figure 1. Early Disease Course in SIV-Infected Macaques
(9/12 macaques at 5 weeks after infection) (Figure 5).
Shown in the panels, from top to bottom, are: SIV plasma virus load This phenomenon of preferential segregation according
(pVL), peripheral blood CD4 T cell count, frequency of TL8-specific
to antigen specificity in immunodominant populationsCD8 T cells, and frequency of CM9-specific CD8 T cells. Each
is likely to explain the major expansions of particularmacaque has a unique identification (ID) number color-coded as
shown in the panel inset. TCRBV families within the CD8 T cell subset that have
been documented previously in acute HIV and SIV infec-
tion (Chen et al., 1995; Pantaleo et al., 1994). Importantly,
however, such limited TCRBV gene usage within anti-therefore provided for MHC class I restriction element
gen-specific CD8 T cell populations does not equateand other immunological variables that could obscure
with oligoclonality (Figures 2–4; Supplemental Figuresthe impact of clonotypic differences, while genetic back-
S1 and S2).ground is fixed. Further, these two responses account
for the vast majority of virus-specific CD8 T cell activity
in this early phase, a situation that is analogous to the Clonal Selection and TCRB CDR3 Motifs
A more detailed examination of the TCRB sequenceshighly focused epitope targeting observed in acute HIV
infection (Borrow et al., 1997; Yu et al., 2002). The Mamu- expressed within these discrete immunodominant SIV-
specific CD8 T cell populations revealed two strikingA*01-restricted TL8- and CM9-specific CD8 T cell pop-
ulations (Figure 1) were labeled directly ex vivo with features. First, a number of CDR3 sequences identical
at the amino acid level were present in multiple ma-the corresponding fluorescent pMHC class I tetrameric
complexes and were sorted by flow cytometry at both 5 caques for both TL8- and CM9-specific responses (43
and 26, respectively); none of the TL8-specific se-and 12 weeks after infection. A novel, modified anchored
reverse transcriptase-polymerase chain reaction (RT- quences in the entire data set were contained within
CM9-specific sequences and vice versa, thereby ex-PCR) was used to amplify all expressed TCRB gene
products without bias (Douek et al., 2002); the resultant cluding artifact (Supplemental Figures S1 and S2). Fur-
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ther, these common antigen-specific clonotypes were confirm this, we constructed a pMamu-A*01 tetrameric
complex containing the 5L variant of the TL8 peptide.distinct within individual macaques at the nucleotide
level; the sequences for each shared clonotype are Importantly, the yield of correctly refolded monomeric
protein was comparable to that obtained by using theshown for all 12 macaques in Supplemental Tables S1
and S2, and for three representative macaques in Table TL8 peptide, and the corresponding tetramer was sta-
ble. In competition assays with pMamu-A*01 tetramers1. This phenomenon, enabled by codon degeneracy,
operated within, as well as between, individual ma- containing the parent peptide, a small fraction of the
TL8-specific polyclonal CD8 T cell population visiblycaques and provides evidence for the selection of T cell
clonotypes by antigenic determinants at the protein level engaged the 5L complex, but with lower avidity com-
pared to the TL8 complex (n  3; Supplemental Figurein a manner analogous to the mechanisms that dictate
the formation of humoral responses (Jerne, 1955). Sec- S4). No significant secondary CD8 T cell responses to
the 5L mutant form of TL8 were detected in functionalond, marked differences were apparent in the molecular
structure of the respective CDR3 regions. Consensus assays at the 12 week time point (n  3; Supplemental
Figure S5). In addition, no specific binding was detectedsequence alignments demonstrated that a highly re-
stricted TCRB CDR3 motif associated with preferential to the 5L variant pMamu-A*01 tetramer at this time point
(n  2; data not shown). This lack of reactivity couldTCRBJ1.5 usage, CASSXXRXSNQPQY, was prevalent
among TL8-specific clonotypic populations and was reflect either poor immunogenicity (Friedrich et al.,
2004c; McAdam et al., 1995), perhaps related to self-conserved in all 12 macaques (Figure 6A). Interestingly,
a motif similarly dominated by a central arginine residue mimicry or a lack of distinguishing structural features,
or a detrimental effect that impairs the generation of decharacterizes human CD8 T cells specific for the immu-
nodominant HLA A2-restricted influenza A epitope (ma- novo variant-specific responses (Ciurea et al., 2001).
Further, the TL8-specific response that drove the initialtrix protein; residues 58–66) (Moss et al., 1991). In con-
trast, no such consensus emerged for CM9-specific emergence of the optimal 5L escape variant had waned
substantially by this time, presumably due to loss ofCD8 T cells (Figure 6B). Although dual expression of
TCRA genes is unlikely to increase the functional clonal stimulation by the original antigen (Figure 1); this might
explain the corresponding changes in the viral popula-repertoire significantly (Nikolich-Zugich et al., 2004), it
limits interpretation of associated TCRA gene usage in tion at the 12 week time point (Figure 6C). In contrast,
the CM9 epitope and adjacent flanking regions remainedterms of contribution to the cognate receptor; however,
a preference for TCRAV22 was clearly exhibited within invariant throughout in all cases (data not shown). Previ-
ous studies have demonstrated that this SIV-derivedTL8-specific populations from three macaques selected
for further study on the basis of maximal TCRB CDR3 CD8 T cell antigen can mutate to evade immune recog-
nition (Barouch et al., 2002; Chen et al., 2000; O’Connormotif conservation at the 5 week time point (Supplemen-
tal Figure S3). et al., 2002; Peyerl et al., 2003). In addition, the CM9-
specific CD8 T cell responses were substantially larger
than the contemporaneous TL8-specific responses atViral Escape Mutations
both time points, which indicates that absolute magni-The markedly different structural recognition profiles of
tude alone is also insufficient to explain differential pat-the cognate CD8 T cell populations were reflected by
terns of immune escape (Figure 1). Thus, for TL8-specificsimilarly distinct outcomes in the corresponding epi-
responses, a highly restricted TCRB CDR3 motif wastope-encoding regions of the viral genome. In all cases,
associated with a uniformly monomorphic escape se-the TL8 epitope mutated rapidly (Figure 6C). More strik-
quence in the cognate viral epitope; in contrast, noingly, in every macaque, the predominant variant antigen
changes were observed in the CM9 epitope, and noassumed an identical form, with a leucine residue replac-
strict antigen recognition motifs were displayed withining serine at position 5 (Figure 6C). In those macaques
the corresponding diverse clonotypic populations (Fig-tested for functional responses at the 5 week time point,
ure 6).this single substitution conferred immune escape prop-
erties that abrogated direct ex vivo recognition by the
entire polyclonal CD8 T cell population generated in Clonotypic Structure and Viral Evolution:
Restricted Recognition Motifsresponse to the founding antigen (n  3; data not
shown). Further, inappropriate proliferation in the ab- The dichotomy between TL8- and CM9-specific CD8
T cell populations with respect to TCRB CDR3 diversitysence of effector function was not detected in response
to the 5L variant of the TL8 peptide; this is consistent is likely to reflect fundamentally different modes of anti-
gen recognition. Analysis of the recently solved crystalwith the collapse of the TL8-specific response at later
time points and argues against a phenomenon akin to structure of an immunodominant influenza A-specific
TCR complexed with its cognate matrix protein (MP 58-original antigenic sin (data not shown) (Klenerman and
Zinkernagel, 1998; Mongkolsapaya et al., 2003). These 66)/HLA A2 counterpart revealed a unique orthogonal
orientation that facilitates insertion of a central CDR3data are in accordance with previous observations that
demonstrate the potency of this particular escape mu- arginine residue into a notch formed on the antigen
surface between the largely flat peptide and the MHCtant in the setting of acute SIVmac239 infection, despite
the fact that the peptide is unaltered at MHC class I class I2 helix (Stewart-Jones et al., 2003). The standard
TCR/pMHC class I interaction, in which an exposed pep-anchor residues and retains the capacity to bind Mamu-
A*01 molecules (Allen et al., 2000). Thus, the mechanism tide antigen side chain provides a docking structure for
TCR engagement, is therefore inverted. Arginine is alsoof escape likely operates at the level of pMHC class I
engagement at the TCR antigen recognition surface. To the predominant residue at position 6 in the highly con-
Immunity
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Figure 2. TL8-Specific CD8 T Cell Clone Analysis
This figure shows the CDR3 amino acid sequence, TCRBV and TCRBJ usage, and the relative frequency of TL8-specific CD8 T cell clones
at 5 weeks (upper panels) and 12 weeks (lower panels) postinfection for three representative macaques (887, 888, and 891). Colored boxes
in the “% frequency” column denote clones within an individual macaque that have the same CDR3 amino acid sequence at 5 weeks and 12
weeks. Colored boxes in the “CDR3 sequence” column denote clones with the same CDR3 amino acid sequence between different macaques.
Clonotypic Determinants of Viral Immune Escape
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Figure 3. CM9-Specific CD8 T Cell Clone Analysis
This figure shows the CDR3 amino acid sequence, TCRBV and TCRBJ usage, and the relative frequency of CM9-specific CD8 T cell clones
at 5 weeks (upper panels) and 12 weeks (lower panels) postinfection for three representative macaques (887, 888, and 891). Other details are
as for Figure 2. The full data set for all 12 macaques is shown in Supplemental Figure S2.
served TL8-specific TCRB CDR3 motif, corresponding and to identify the physical basis for subversion of rec-
ognition by the 5L escape mutant. However, regardlessto position 110 in IMGT nomenclature (Lefranc et al.,
2003) (position 98 in Kabat nomenclature). Thus, it is of the precise structural mechanism, the entire poly-
clonal TL8-specific CD8 T cell response is renderedtempting to speculate that the TL8-specific TCR/
pMamu-A*01 interaction might follow the precedent set ineffectual by a single residue mutation in the cognate
viral antigen as a consequence of the restricted TCRBby the HLA A2-restricted influenza A MP-specific TCR
at the level of tertiary structure. In this scenario, spatial CDR3 motif diversity that likely reflects a limited mode of
antigen recognition. It is possible that distinct clonotypicand/or electrochemical constraints imposed by the piv-
otal role of the central arginine could limit the flexibility structures such as those that characterize the re-
sponses to influenza A MP/HLA A2 and SIV TL8/Mamu-of antigen recognition and facilitate viral escape. Crys-
tallographic studies are in progress to characterize the A*01, also referred to as “public repertoires” (Cibotti
et al., 1994; Gavin and Bevan, 1995), allow the rapiddominant TL8-specific TCR/pMamu-A*01 interaction
TCRBV families correspond to macaque sequences with the closest match to defined human TCRBV. Arden’s nomenclature is used (Arden
et al., 1995). For correspondence to IMGT nomenclature, see http://imgt.cines.fr:8104/textes/IMGTrepertoire/LocusGenes/nomenclatures/
human/TRB/TRBV/Hu_TRBVnom.html. The full data set for all 12 macaques is shown in Supplemental Figure S1.
Immunity
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Figure 4. Clonality of SIV-Specific CD8 T Cell Responses in Each Macaque
(A–F) Panels show the number and relative frequency of individual T cell clones, as defined by unique TCRB CDR3, that are specific for TL8
at (A) 5 and (B) 12 weeks, and CM9 at (D) 5 and (E) 12 weeks postinfection. The dominant frequency at 12 weeks for TL8-specific clones was
95% in macaque 893 and 100% in macaque 896; for CM9-specific clones, the dominant frequency was 53% in macaque 891 and 94% in
macaque 896. Also shown is the statistical comparison of clone numbers at each time point for (C) TL8-specific clones and (F) CM9-specific
clones in each macaque. The horizontal bar represents the median for all macaques. The colorcoding scheme is the same as that used in
Figure 1.
mobilization of early immune responses through “pat- Indeed, given the codon degeneracy for arginine, this
particular residue might be relatively overrepresentedtern recognition” of peptides exhibiting certain generic
properties and thereby determine the selection of immu- as a component of TCRB CDR3 regions in the naı¨ve T cell
pool; preferential usage of such T cells for appropriatenodominant epitopes in the acute phases of infection.
Figure 5. TCRBV Usage of SIV-Specific CD8 T Cell Clones
Each pie chart shows the relative TCRBV usage of TL8-specific (upper panels) and CM9-specific (lower panels) T cell clones at both time
points for each macaque (ID shown at top). The color code for TCRBV families is shown at the bottom and corresponds to the macaque
sequence that is the closest match to defined human TCRBV. Arden’s nomenclature is used (Arden et al., 1995). For correspondence to the
IMGT nomenclature, see http://imgt.cines.fr:8104/textes/IMGTrepertoire/LocusGenes/nomenclatures/human/TRB/TRBV/Hu_TRBVnom.html.
TCRBV and TCRBJ usage and the CDR3 amino acid sequence of every clone in every macaque at both time points for TL8-specific and
CM9-specific responses can be viewed in Supplemental Figures S1 and S2, respectively.
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Table 1. TL8- and CM9-Specific Clone TCRB CDR3 Nucleotide Alignments in Macaques 887, 888, and 891
Each section defines a CDR3 amino acid sequence and, below that, the CDR3 nucleotide alignments of all corresponding clones in each
macaque at the 5 and/or 12 week time points. The full data set for all 12 macaques is shown in Supplemental Tables S1 and S2.
cognate epitopes during acute infection could be ex- functional crossreactivity (Charini et al., 2001; Douek et
plained on a kinetic basis by such precursor prevalence. al., 2002). The corollary of this tolerance for epitope
If these considerations hold as a general principle, then variation at the TCR interface is that optimal escape
vaccine strategies that mimic the natural immune re- mutations become mechanistically limited largely to
sponse in acute infection are unlikely to be successful those that interfere with either MHC class I binding or
(Allen et al., 2002). antigen processing (Chen et al., 2000). Consequently, it
becomes more likely, in terms of probability, that an
escape mutation will be associated with concomitantClonotypic Structure and Viral Evolution:
adverse effects on viral fitness simply because thereDiverse Recognition Motifs
are fewer potential residue changes that can bestowIn contrast, the clonotypic diversity that distinguishes
immune evasion capabilities. Indeed, this phenomenonthe CM9-specific response almost certainly imbues
has been elegantly demonstrated for the CM9 consen-these CD8 T cell populations with promiscuous recog-
sus 2A escape mutation, although it remains to be deter-nition properties such that a greater degree of antigenic
mutation can be encompassed within the spectrum of mined whether other residues in this epitope could be
Immunity
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Figure 6. TCRB CDR3, and SIV Epitope Amino Acid Sequences
(A) Consensus TCRB CDR3 amino acid motifs for TL8-specific clones at week 5. For each macaque, the consensus amino acid sequence of
the TCRB CDR3 of all TL8-specific clones is shown. The color code for each residue corresponds to the percentage of TCRB CDR3 sequences
with identity to the consensus, and the key is shown at the bottom. “x” represents no consensus amino acids at that position. The numbering
scheme of amino acid residue positions within the CDR3 is shown at the top of the panel. Position 6 of the CDR3 corresponds to residue
110 of the full TCRBV sequence (IMGT nomenclature) (Lefranc et al., 2003). Although the majority of CDR3 were 13 residues in length, a few
were longer due to the insertion of additional amino acids between positions 7 and 8. Thus, the last column of the panel shows the maximum
number of additional residues observed in any TCRB CDR3 compared to the consensus length. A similar pattern was preserved in the majority
of macaques at week 12, despite the dramatic decrease in overall response magnitude (data not shown).
(B) Consensus TCRB CDR3 amino acid motifs for CM9-specific clones at week 5; panel details are the same as for (A).
(C) Amino acid sequences of the TL8 epitope, including the two flanking residues, are shown for each macaque at both time points, followed
by the frequency of each out of a total of ten sequences analyzed. The predominant mutation at P5 is shaded yellow.
mutated with less detriment to viral replicative capacity design of an effective AIDS virus vaccine (Allen et al.,
2000; Barouch et al., 2002; Borrow et al., 1997; Johnson(Friedrich et al., 2004a, 2004b; Peyerl et al., 2003). Such
CD8 T cell responses that drive the evolution of viral and Desrosiers, 2002; Letvin and Walker, 2003; McMi-
chael, 1998; O’Connor et al., 2002; Price et al., 1997).variants with impaired replicative competence could of-
fer hope for improved immune control and amelioration The findings presented here illuminate the mechanisms
that underlie observed patterns of mutational immuneof HIV-associated disease (Matano et al., 2004).
escape and expose the potential frailties of CD8 T cell
responses that are generated naturally during primaryConcluding Remarks
Retroviral mutants that escape immune recognition dur- infection. Analyses of TCR/pMHC class I structures sug-
gest that amino acid substitutions in the bound peptideing acute infection are a formidable challenge to the
Clonotypic Determinants of Viral Immune Escape
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Flow Cytometric Sortingat any position, including anchor residues, can often
All sorts were performed on stained cells by using a modified FACSaffect TCR recognition as a consequence of transmitted
DIVA (Becton Dickinson). Instrument set-up was performed ac-shifts in epitope orientation (Achour et al., 2002; Denk-
cording to the manufacturer’s instructions. All sorts were performed
berg et al., 2002; Kersh et al., 2001; Reid et al., 1996; at 25 PSI. Electronic compensation was conducted with antibody-
Tissot et al., 2000; Velloso et al., 2004); thus, the impact capture beads (Becton Dickinson) stained separately with individual
mAbs used in the test samples. Post-sort purity was consistentlyof antigen variation at the TCR contact surface is likely
99% (Supplemental Figure S6).to be paramount. In this light, vaccination strategies that
target antigens structurally amenable to the generation
of CD8 T cell responses with diverse clonotypic reper- Clonotype Analysis
toires might prove efficacious, especially if such epi- Antigen-specific CD8 T cells gated on the parameters described
above were sorted directly into collection tubes containing 100 ltopes are derived from biologically constrained regions
RNAlater (Ambion). After cell lysis, mRNA was extracted (Oligotexof the virus. Alternatively, flexibility of variant recognition
Kit) and subjected to template switch-anchored RT-PCR by usingmight be incorporated by covaccination with common
a 3 TCRB constant region primer (5-TGCTTCTGATGGCTCAAACA
escape variants that retain MHC class I binding proper- CAGCGACCT-3) as described previously (Douek et al., 2002). A
ties (Singh et al., 2002). In either case, an approach to 3 TCRAC primer (5-AATAGGCAGACAGACGTGTCATTGGATT-3)
the qualitative modulation of CD8 T cell responses is based on published sequences was used to characterize  chain
usage (Thiel et al., 1995). Amplicons were ligated into pGEM-T Easysuggested that could both minimize the development of
vector (Promega) and cloned by transformation of competent DH5immune escape and alleviate its consequences. Further
E. coli. Selected colonies were amplified by PCR with standardstudies are indicated to determine both the feasibility
M13 primers and then sequenced. A minimum of 50 clones were
of vaccine strategies that direct the adaptive immune generated and analyzed per sample. Pseudogenes and “nonfunc-
response to preempt viral evolution and the extent to tional” sequences that could not be resolved after inspection of
which such principles might be applicable to outbred the individual chromatograms were discarded from the analysis.
Nucleotide comparisons were used to establish clonal identity.human populations exposed to heterogeneous viral in-
CDR3 consensus sequences were compiled and aligned with Mac-ocula.
Vector 7.2.
Experimental Procedures
Quality Control
The entire procedure, from the detection and sorting of SIV-specificAnimals
CD8 T cells to the molecular analysis of clonotypic composition,Twelve colony-bred rhesus macaques (Macaca mulatta), obtained
was repeated periodically for quality control. In every case, thefrom Covance Research Products, were housed and handled in
results were almost identical. Formal statistical analysis showed noaccordance with the standards of the American Association for the
significant correlation between clonal diversity and the number ofAccreditation of Laboratory Animal Care. Macaques were infected
clones analyzed.intravenously with a SIVmac251 stock as described (Nacsa et al.,
2003; Tryniszewska et al., 2002); the TL8 (Tat, residues 28–35) and
CM9 (Gag, residues 181–189) epitope sequences in the inoculum
Viral RNA Sequencingwere TTPESANL and CTPYDINQM, respectively.
SIV was isolated from frozen plasma by centrifugation at 25,000 
g for 1 hr and lysed with 48% guanidine thiocyanate, 1.4% dithi-
Tetrameric Antigen Complexes othreitol, 1% N-laurolylsarcosine, and 1% sodium citrate. RNA was
Soluble biotinylated pMamu-A*01 monomers were produced as de- precipitated with isopropanol and solubilized. cDNA was synthe-
scribed previously (Kuroda et al., 1998). Fluorescent tetrameric com- sized by using SIV gag primer 5-TGTTTGTTCTGCTCTTAAGCTTTT
plexes were prepared from monomeric protein by the addition of GTAG-3 or SIV pol primer 5-ATGCCATGAGAAATGCTTCCA-3.
phycoerythrin (PE)- or allophycocyanin (APC)-conjugated streptavi- PCR procedures for TL8 and CM9 epitopes were as described pre-
din (Prozyme) at a 4:1 molar ratio, respectively. viously (Barouch et al., 2002). Amplified fragments were cloned into
pCRII-TOPO (Invitrogen) or pAMPI (Strategene), and transformed
colonies were subjected to T7/M13R dideoxy sequencing.
Identification of SIV-Specific CD8 T Cells
Functional assays to detect intracellular IFN production and coex-
pression of CD25/CD69 activation markers were performed on Statistical Analysis
PBMC by using procedures modified from previous descriptions Spearman’s Rank correlations and Wilcoxon matched pairs tests
(Pitcher et al., 1999). Freshly isolated or thawed PBMC were resus- were performed by using Prism 4.0 software.
pended at 106/ml in RPMI medium (Invitrogen) supplemented with
10% heat-inactivated fetal calf serum, penicillin (100 U/ml), strepto-
mycin (100g/ml), glutamine (2 mM), and anti-CD28 and anti-CD49d Supplemental Data
Supplemental Data including the TCRB CDR3 amino acid sequence,monoclonal antibodies (mAbs) at 1 g/ml (Becton Dickinson). Pep-
tides corresponding to the autologous TL8 wild-type and 5L mutant TCRBV and TCRBJ usage, and the relative frequency of TL8- and
CM9-specific CD8 T cell clones from all 12 macaques at 5 and 12virus sequences (purity 95%; Bio-Synthesis) were used at 2 g/
ml to stimulate SIV-specific CD8 T cells. Costimulatory antibodies weeks after infection (Supplemental Figures S1 and S2); nucleotide
alignments for shared TCRB CDR3 sequences in the TL8- and CM9-alone were used as a negative control, with Staphylococcus entero-
toxin B (SEB; Sigma) at 1 g/ml as a positive control, in every specific CD8 T cell clonotype data sets (Supplemental Tables S1
and S2); the TCRA CDR3 amino acid sequence, TCRAV usage, andexperiment. Proliferation assays were based on carboxyfluorescein
diacetate succinimidyl ester (CFDA-SE) dilution as described pre- the relative frequency of TL8-specific CD8 T cell clones in 3 ma-
caques at 5 weeks after infection (Supplemental Figure S3); compet-viously (Brenchley et al., 2002). Physical identification of SIV-specific
CD8 T cells based on surface expression of cognate TCR was itive assays of CD8 T cell avidity using wild-type and 5L mutant
TL8 pMamu-A*01 tetrameric complexes (Supplemental Figure S4);accomplished by concurrent staining with pretitred tetrameric
pMamu-A*01 complexes labeled with PE (TL8) or APC (CM9) in the functional assays of CD8 T cell response using wild-type and 5L
mutant TL8 peptides (Supplemental Figure S5); a representativeabsence of stimulation (Kuroda et al., 1998); cells were subsequently
stained with anti-CD8(Cy5PE) and anti-CD3(FITC) mAbs (Becton analysis of population purity after flow cytometric cell sorting (Sup-
plemental Figure S6); and corresponding legends for each of theDickinson) prior to bidirectional sorting. Tetramer competition
assays were similarly performed with distinct fluorescent labels for eight display items are available at http://www.immunity.com/cgi/
content/full/21/6/793/DC1/.TL8 and 5L mutant pMamu-A*01 complexes.
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